Author:
Chaganti Sowmya,Chauhan Usha,Bhatt Nehal,Kommalapati Hemasree,Golla Vijaya Madhyanapu,Pilli Pushpa,Samanthula Gananadhamu
Reference28 articles.
1. Calcitonin gene-related peptide: physiology and pathophysiology;Russell;Physiol. Rev.,2014
2. Characterisation of the calcitonin gene-related peptide receptor antagonists ubrogepant and atogepant in human isolated coronary, cerebral and middle meningeal arteries;Rubio-Beltran;Cephalalgia,2020
3. Ubrogepant: first approval;Scott;Drugs,2020
4. USFDA, UBRELVY (ubrogepant) tablets, for oral use. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211765s000lbl.pdf (Accessed date: January, 2024).
5. National Center for Biotechnology Information. PubChem Compound Summary for CID 68748835, Ubrogepant. https://pubchem.ncbi.nlm.nih.gov/compound/Ubrogepant, (Accessed date: 17 January, 2024).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献